15 Anti-SARS Drugs Identified By China-Europe Team of Researchers ( SARS (severe acute respiratory syndrome...)

15 Anti-SARS Drugs Identified By China-Europe Team of Researchers

SARS (severe acute respiratory syndrome) has been a major killer in the last two years in July 2003; SARS had killed // 774 people worldwide and infected a further 8,000. A collaborative group of researchers from China, Germany, Denmark and Poland have spent the past year screening more than 8,000 existing drugs to find those that could combat SARS and now have identified 15 existing drugs that have the potential to kill the virus that causes SARS. This three-year research collaboration is funded by the European Commission and was launched in 2004 to identify 50 compounds that have the potential to treat SARS.

A paper published last month by the group in the Journal of Virology showed one such compound called Cinanserin can stop the SARS virus from replicating. Interestingly cinanserin, was approved in the United States for clinical use in the 1960s to treat schizophrenia and other psychopathic diseases. Shen one of the researchers said that: ‘cinanserin could not form a SARS treatment on its own, but would need to be used in combination with other drugs’. As it is an old safe and cheap drug, it could be used widely for SARS patients in the developing world.

China is also working on vaccines against SARS epidemics. The first phase trials have already been completed in December and the second phase is to start soon as per a news release on 29 June.

Source: SciDev.Net

Page: 1
Related medicine news :

1. Tech Wizards turn to build Anti-SARS gadgets.
2. Lean Protein Could Be Key to Obesity Drugs
3. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Emphasis to ban Drugs ads by Doctors
6. Osteoporosis Drugs: right time to take-off
7. Drugs disrupt formation of blood vessels
8. Drugs to stop burgeon of HIV
9. Misleading Advertisements for Prescription Drugs
10. Drugs For Anthrax May Interfere With Oral Contraceptives
11. Over-The-Counter Drugs May Prevent Alzheimers

Post Your Comments:

(Date:5/16/2008)... ED Rebecca Haag,s Statement for National HIV ... /PRNewswire-USNewswire/ -- Twenty-six years into ...HIV every 13 minutes in the,U.S. On Sunday, May 18...ive,national partners in the National Institute of...e Research Education Initiative, urges everyone,to...

(Date:5/16/2008)... LONDON, May 16 /PRNewswire/ -- Huntsworth plc...public relations and healthcare communications,gro...anagement report with,respect to the Group,s perfo...g March 31, 2008)., The statement follows below...sworth plc, Interim Manageme...

(Date:5/16/2008)... Research Funding Per Death Drops More in 2007...hile lung cancer causes,one in three cancer deaths...s than 5% of its $4.8 billion budget in lung cance...s issued by Lung Cancer Alliance (LCA) today., Th...er research,programs -- Centers for Disease Contro...

(Date:5/16/2008)... Financial Highlights:, - 2007 Comprehensive...enue increased 29% to $15.9 million, - 2007 Gross...ch 31, 2008 increased 410% to $12.2 million fro... China, May 16 /Xinhua-PRNewswire-FirstCall/ -- Hu...OTC Bulletin Board: HHGM), a,China-based leader in...

[0] AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine [0] Huntsworth plc Releases Interim Statement on First Quarter 2008 [0] Lung Cancer Still Lowest in Federal Funding [0] Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008

...ugh shine, making Washington, a hot spot for sun-l... the Environmental// Protection Agency. The EPA... kits to schools that comprise of 40 activity card...hanges color to purple when exposed to the sun's U...

...ates that the type 2 diabetes may be prevalent amo...lion have been projected to have impaired blood gl... increased risk of diabetes and other serious heal...nted in the Archives of Pediatrics & Adolescent Me...

...ease in the development of diabetes and other card...ckle the issue frequent blood glucose and lipid te...d prevent the development of the disease and other...oom, M.D., Children’s Medical Services Center, Gai...

... a new vaccine, believed to fight against glioblas...he vaccine is hoped to fight brain tumor by delayi...creased survival rates by at least 18 months for t...rme that it was tested on, reported the online edi...

Other Medicine News:

Seattle, a hub for malignant melanoma? Time To Get Sunwise!Survey Reveals Alarming Prevalence Rates of Diabetes among US Adolescents Early Monitoring Of Diabetes among Teens New Brain Tumor Vaccine Developed By US Scientists

(Date:5/15/2008)...ay 15 /- Medivation, Inc.,(...ongoing Phase 1-2 clinical,trial of its novel andr...ed,in an oral presentation at the 44th American So...n Chicago., Session title: New Targeted Strateg...e and time: Monday, June 2 at 11:30 a.m. Central T...

(Date:5/15/2008)...alia, May 15 /- Cytopia Lim...for its upcoming oral,presentation on CYT997 at th...linical Oncology (ASCO) will be accessible to the ...from 9pm on Thursday 15 May (US EDT)., The oral p...7, a novel,cytotoxic and vascular disrupting agent...

(Date:5/15/2008)...., May 15 /- Sanofi-aventis...t findings from the,landmark ATHENA study showed M...e treatment of patients with atrial fibrillation o...ular hospitalizations or death from any,cause by a...ting the study,primary endpoint. The ATHENA result...

(Date:5/15/2008)...- CenterWatch, a publishing and,infor... about clinical,trials, finds that investigative s...c data capture) systems. More than 75% of responde...they had been trained on three or more,EDC systems...tiveness of,their EDC training had improved., Sta...

Breaking Medicine Technology:Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2 Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7 CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2 Kiwa Bio Tech Ships 2 700 Tons of Bio feed in One Month 986 1 Kiwa Bio Tech Ships 2 700 Tons of Bio feed in One Month 986 2 Experts Issue Guidelines on Treating Low Back Pain 2607 1 Experts Issue Guidelines on Treating Low Back Pain 2607 2 Black gay men lesbians have fewer mental disorders than whites says Mailman School of PH study 2604 1 Black gay men lesbians have fewer mental disorders than whites says Mailman School of PH study 2604 2 A greenhouse in order to study the impact of climate change on plants 642 1 A greenhouse in order to study the impact of climate change on plants 642 2

[1] Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting [0] Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology [3] Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation [0] CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence

...SBROUCK HEIGHTS, NJ (June 21, 2007) Nymox Pharmace...that detailed results,from the Company’s rec...tatic hyperplasia (BPH) will be presented at a ser...n September at the South,Central American Urologic...independent podium presentations will be given by,...

...T LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neuro...cation in the June 23 issue,of the journal The Lan...herapy trial for Parkinson,s disease and the first...wn brain cells for any adult,neurodegenerative dis...12 patients with,advanced Parkinson,s disease demo...

Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2 Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 3 Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2 Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3 Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4 Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5 Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6

Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease

...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...

Medicine Products:

Allergen, Weed, Sheep Sorrel Allergen, Weed, Yellow Dock (Rumex crispus)Allergen, Weed, Goldenrod Allergen, Tree, Willow Tree

( SARS (severe acute respiratory syndrome...)15 Anti-SARS Drugs Identified By China-Europe Team of Researchers ,Health